Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Universus Photo Imagings's 5-Year Yield-on-Cost % or its related term are showing as below:
NSE:UNIVPHOTO's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.48 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Universus Photo Imagings 5-Year Yield-on-Cost % Related Terms
NSE:UNIVPHOTO vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Universus Photo Imagings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universus Photo Imagings 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Universus Photo Imagings's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Universus Photo Imagings's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Universus Photo Imagings (NSE:UNIVPHOTO) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 26, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Universus Photo Imagings and its competitors. According to the industry distribution chart, Universus Photo Imagings ranks #999999 out of 324 companies in the Medical Devices & Instruments industry.
Is Universus Photo Imagings' 5-Year Yield-on-Cost % too high?
Universus Photo Imagings' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Universus Photo Imagings ranks #999999 out of 324 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Universus Photo Imagings has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Universus Photo Imagings' 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Universus Photo Imagings ranks #999999 out of 324 companies for 5-Year Yield-on-Cost %. This places Universus Photo Imagings in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.48, based on 324 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Universus Photo Imagings and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Universus Photo Imagings's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universus Photo Imagings stock overvalued right now?
Based on GuruFocus' analysis, Universus Photo Imagings (NSE:UNIVPHOTO) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹174.65, compared to a current price of ₹475.75 — trading 172.4% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Universus Photo Imagings' overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Universus Photo Imagings (NSE:UNIVPHOTO), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Universus Photo Imagings (NSE:UNIVPHOTO) Overvalued in 2026?
Based on GuruFocus' analysis, Universus Photo Imagings stock appears to be overvalued.
The current stock price of ₹475.75 is trading 172.4% above its estimated GF Value™ of ₹174.65.
GuruFocus considers Universus Photo Imagings to be Significantly Overvalued.
Key valuation signals for NSE:UNIVPHOTO:
5-Year Yield-on-Cost %: 0.00
GF Value™: ₹174.65 vs. price of ₹475.75 (172.4% above fair value)
No single metric tells the full story. See the NSE:UNIVPHOTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Universus Photo Imagings Ltd specializes in manufacturing, selling, distributing, converting, and producing X-ray films and NTR (non-toxic radiographic) films with matt and glossy finishes. These films are used for medical imaging and various photographic applications such as photo albums, certificates, playing cards, gift cards, visiting cards, calendars, menu cards, wedding cards, and modeling portfolios. The company operates a high-tech manufacturing facility located at Dadra in the Union Territory of Dadra and Nagar Haveli, India. Revenue is generated through the sale of these imaging products to medical and photographic industries.
53GF Score
Get the complete analysis for NSE:UNIVPHOTO
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:UNIVPHOTO has been successfully added to your 
